Kurs
-5,29%
Likviditet
91,8 MDKK
Kalender
Tid* | ||
2025-12-03 | N/A | Årsstämma |
2025-11-05 | 08:00 | Bokslutskommuniké 2025 |
2025-08-22 | 07:00 | Kvartalsrapport 2025-Q3 |
2025-05-07 | 07:00 | Kvartalsrapport 2025-Q2 |
2025-01-30 | 07:00 | Kvartalsrapport 2025-Q1 |
2024-12-05 | - | X-dag ordinarie utdelning AMBU B 0.38 DKK |
2024-12-04 | - | Årsstämma |
2024-11-05 | - | Bokslutskommuniké 2024 |
2024-08-30 | - | Kvartalsrapport 2024-Q3 |
2024-05-14 | - | Kvartalsrapport 2024-Q2 |
2024-01-30 | - | Kvartalsrapport 2024-Q1 |
2023-12-14 | - | X-dag ordinarie utdelning AMBU B 0.00 DKK |
2023-12-13 | - | Årsstämma |
2023-11-08 | - | Bokslutskommuniké 2023 |
2023-08-31 | - | Kvartalsrapport 2023-Q3 |
2023-05-03 | - | Kvartalsrapport 2023-Q2 |
2023-02-07 | - | Kvartalsrapport 2023-Q1 |
2022-12-15 | - | X-dag ordinarie utdelning AMBU B 0.00 DKK |
2022-12-14 | - | Årsstämma |
2022-11-15 | - | Bokslutskommuniké 2022 |
2022-08-25 | - | Kvartalsrapport 2022-Q3 |
2022-05-10 | - | Kvartalsrapport 2022-Q2 |
2022-02-08 | - | Kvartalsrapport 2022-Q1 |
2021-12-15 | - | X-dag ordinarie utdelning AMBU B 0.29 DKK |
2021-12-14 | - | Årsstämma |
2021-11-09 | - | Bokslutskommuniké 2021 |
2021-08-17 | - | Kvartalsrapport 2021-Q3 |
2021-05-12 | - | Kvartalsrapport 2021-Q2 |
2021-01-27 | - | Kvartalsrapport 2021-Q1 |
2020-12-10 | - | X-dag ordinarie utdelning AMBU B 0.29 DKK |
2020-12-09 | - | Årsstämma |
2020-11-11 | - | Bokslutskommuniké 2020 |
2020-08-26 | - | Kvartalsrapport 2020-Q3 |
2020-05-05 | - | Kvartalsrapport 2020-Q2 |
2020-02-04 | - | Kvartalsrapport 2020-Q1 |
2019-12-18 | - | X-dag ordinarie utdelning AMBU B 0.38 DKK |
2019-12-17 | - | Årsstämma |
2019-11-13 | - | Bokslutskommuniké 2019 |
2019-08-22 | - | Kvartalsrapport 2019-Q3 |
2019-05-01 | - | Kvartalsrapport 2019-Q2 |
2019-01-31 | - | Kvartalsrapport 2019-Q1 |
2018-12-13 | - | X-dag ordinarie utdelning AMBU B 0.40 DKK |
2018-12-12 | - | Årsstämma |
2018-11-13 | - | Bokslutskommuniké 2018 |
2018-08-23 | - | Kvartalsrapport 2018-Q3 |
2018-05-07 | - | Kvartalsrapport 2018-Q2 |
2018-01-31 | - | Kvartalsrapport 2018-Q1 |
2018-01-03 | - | Split AMBU B 1:5 |
2017-12-14 | - | X-dag ordinarie utdelning AMBU B 1.85 DKK |
2017-12-13 | - | Årsstämma |
2017-09-30 | - | Bokslutskommuniké 2017 |
2017-08-23 | - | Kvartalsrapport 2017-Q3 |
2017-05-02 | - | Kvartalsrapport 2017-Q2 |
2017-02-01 | - | Kvartalsrapport 2017-Q1 |
2016-12-13 | - | X-dag ordinarie utdelning AMBU B 1.55 DKK |
2016-12-12 | - | Årsstämma |
2016-09-30 | - | Bokslutskommuniké 2016 |
2016-08-19 | - | Kvartalsrapport 2016-Q3 |
2016-05-03 | - | Kvartalsrapport 2016-Q2 |
2016-01-29 | - | Kvartalsrapport 2016-Q1 |
2015-12-11 | - | X-dag ordinarie utdelning AMBU B 0.95 DKK |
2015-12-10 | - | Årsstämma |
2015-11-11 | - | Bokslutskommuniké 2015 |
2015-08-19 | - | Kvartalsrapport 2015-Q3 |
2015-05-06 | - | Kvartalsrapport 2015-Q2 |
2015-02-02 | - | Kvartalsrapport 2015-Q1 |
2014-12-23 | - | Split AMBU B 1:4 |
2014-12-18 | - | X-dag ordinarie utdelning AMBU B 3.75 DKK |
2014-12-17 | - | Årsstämma |
2014-11-13 | - | Bokslutskommuniké 2014 |
2014-08-20 | - | Kvartalsrapport 2014-Q3 |
2014-05-02 | - | Kvartalsrapport 2014-Q2 |
2014-02-04 | - | Kvartalsrapport 2014-Q1 |
2013-12-13 | - | X-dag ordinarie utdelning AMBU B 1.25 DKK |
2013-12-12 | - | Årsstämma |
2013-09-30 | - | Bokslutskommuniké 2013 |
2013-08-20 | - | Kvartalsrapport 2013-Q3 |
2013-05-02 | - | Kvartalsrapport 2013-Q2 |
2013-02-05 | - | Kvartalsrapport 2013-Q1 |
2012-12-14 | - | X-dag ordinarie utdelning AMBU B 3.00 DKK |
2012-12-13 | - | Årsstämma |
2012-09-30 | - | Bokslutskommuniké 2012 |
2012-08-23 | - | Kvartalsrapport 2012-Q3 |
2012-05-03 | - | Kvartalsrapport 2012-Q2 |
2012-02-09 | - | Kvartalsrapport 2012-Q1 |
2011-12-16 | - | X-dag ordinarie utdelning AMBU B 2.00 DKK |
2011-12-15 | - | Årsstämma |
2011-09-30 | - | Bokslutskommuniké 2011 |
2011-08-25 | - | Kvartalsrapport 2011-Q3 |
2011-05-09 | - | Kvartalsrapport 2011-Q2 |
2011-02-07 | - | Kvartalsrapport 2011-Q1 |
2010-12-17 | - | X-dag ordinarie utdelning AMBU B 2.50 DKK |
2009-12-17 | - | X-dag ordinarie utdelning AMBU B 1.50 DKK |
2005-03-01 | - | Split AMBU B 1:2 |
2004-02-10 | - | Split AMBU B 1:10 |
Beskrivning
Land | Danmark |
---|---|
Lista | Large Cap Copenhagen |
Sektor | Hälsovård |
Industri | Medicinteknik |
Thomas Frederik Schmidt will step down as CFO of Ambu by 31 December 2023; Henrik Skak Bender named as new CFO, effective 1 January 2024.
Ambu A/S has appointed Henrik Skak Bender as the company’s new Chief Financial Officer and member of the Executive Management, effective 1 January 2024. Henrik succeeds Thomas Frederik Schmidt, who will step down, effective 31 December 2023.
During Thomas’ period as CFO, the financial situation of Ambu has stabilised, the company has returned to positive free cash flow ahead of plan and reduced its gearing to a low level, and first steps have been taken towards strong profitable growth. During the next phase of the strategy, Ambu will zoom in on accelerating growth, while delivering improved profitability. Henrik Skak Bender will take on the CFO leadership during this phase, leveraging his strategic and operational experience from international companies to drive efficiency, agility and growth.
"In the progression of Ambu’s ZOOM IN strategy, I have, together with the Board, decided to bring in a new leadership profile to execute on the next phase of Ambu’s transformation and growth journey. I am convinced that Henrik is the right profile for the CFO role at Ambu, as he brings strategic and operational experience from global companies, as well as the medical device industry. On behalf of myself and the Board, I want to thank Thomas for his contributions to Ambu, and I wish him the best for the future."
BRITT MEELBY JENSEN
Chief Executive Officer at Ambu
STRONG PROFILE WITHIN MEDICAL DEVICES AND GROWTH TRANSFORMATIONS
During the past 20 years, Henrik has worked at leading international companies, such as WS Audiology, Urban Partners, McKinsey & Co and A.P. Moller-Maersk. At the hearing aid company, WS Audiology, he served as CFO and Head of Integration, leading the finance, IT, legal and procurement functions. Prior to that, he served as CFO at Widex, where he was responsible for developing and executing the company’s growth and transformation strategy, together with the rest of the management team.
Most recently, Henrik joins from the asset management company, Urban Partners, where he serves as a member of the executive management, leading the company to grow from a Nordic player with EUR 6bn in assets under management in 2020 to a Northern European player with EUR +20bn in assets under management. At Urban Partners, Henrik held a position as Partner and COO, where he focused on driving and scaling a wide range of functions, including Investor Relations, Finance, IT and Sustainability.
With his entry into Ambu, Henrik is looking forward to returning to the medical devices industry and to making an impact on the company’s growth and transformation journey:
"I am very excited to join Ambu at such a pivotal time in the company’s transformation journey, playing my part in unlocking Ambu’s significant potential. Throughout my career, my drive has been to create sustainable long-term impact by building and leading high-performing teams of people who want to make a real difference. I am looking forward to working with my future Ambu colleagues to deliver on the strategy, as well as engaging with analysts, investors and partners to drive strong long-term stakeholder and shareholder value."
HENRIK SKAK BENDER
Upcoming Chief Financial Officer at Ambu, as of 1 January 2024
Ambu A/S
Baltorpbakken 13
2750 Ballerup
Denmark
Tel. +45 7225 2000
CVR no.: 63 64 49 19
www.Ambu.com
CONTACT
Investors
Anders Hjort
Head of Investor Relations
anhj@ambu.com
+45 2892 8881
Media
Tine Bjørn Schmidt
Head of Corporate Communications
tisc@ambu.com
+45 2264 0697
ABOUT AMBU
Ever since 1937, Ambu has been rethinking medical solutions to save lives and improve patient care. Millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia, and patient monitoring solutions. Today, we continue to collaborate with leading medical experts to deliver innovations that make a real difference to healthcare professionals and their patients. At our headquarters in Copenhagen, Denmark, and around the world in Europe, North America, Latin America and the Asia Pacific, 4,500 team members keep Ambu moving forward. For more information, please visit Ambu.com.